Damaskos, C.; Garmpis, N.; Garmpi, A.; Nikolettos, K.; Sarantis, P.; Georgakopoulou, V.E.; Nonni, A.; Schizas, D.; Antoniou, E.A.; Karamouzis, M.V.;
et al. Investigational Drug Treatments for Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 652.
https://doi.org/10.3390/jpm11070652
AMA Style
Damaskos C, Garmpis N, Garmpi A, Nikolettos K, Sarantis P, Georgakopoulou VE, Nonni A, Schizas D, Antoniou EA, Karamouzis MV,
et al. Investigational Drug Treatments for Triple-Negative Breast Cancer. Journal of Personalized Medicine. 2021; 11(7):652.
https://doi.org/10.3390/jpm11070652
Chicago/Turabian Style
Damaskos, Christos, Nikolaos Garmpis, Anna Garmpi, Konstantinos Nikolettos, Panagiotis Sarantis, Vasiliki E. Georgakopoulou, Afroditi Nonni, Dimitrios Schizas, Efstathios A. Antoniou, Michalis V. Karamouzis,
and et al. 2021. "Investigational Drug Treatments for Triple-Negative Breast Cancer" Journal of Personalized Medicine 11, no. 7: 652.
https://doi.org/10.3390/jpm11070652
APA Style
Damaskos, C., Garmpis, N., Garmpi, A., Nikolettos, K., Sarantis, P., Georgakopoulou, V. E., Nonni, A., Schizas, D., Antoniou, E. A., Karamouzis, M. V., Nikolettos, N., Kontzoglou, K., Patsouras, A., Voutyritsa, E., Syllaios, A., Koustas, E., Trakas, N., & Dimitroulis, D.
(2021). Investigational Drug Treatments for Triple-Negative Breast Cancer. Journal of Personalized Medicine, 11(7), 652.
https://doi.org/10.3390/jpm11070652
